SIGN IN
Summer 2025 MBA Interns | Business Leadership Development Program (BuiLD) jobs in United States
info-icon
This job has closed.
company-logo

Regeneron · 10 months ago

Summer 2025 MBA Interns | Business Leadership Development Program (BuiLD)

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines, and they are seeking 1st Year MBA students for their BuiLD MBA Summer internship program. Interns will work on high-impact projects, gain exposure to senior leadership, and collaborate within a world-class organization.
BiotechnologyPharmaceuticalBiopharma
check
Comp. & Benefits

Responsibilities

Working on meaningful, high-impact projects
Gaining exposure to senior leadership through Lunch & Learns and other events
Presenting a final project to senior leaders including the BuiLD board
Participating in team building and other fun events with the BuiLD community
Experiencing Regeneron’s amazing culture firsthand
Collaborating, learning, and growing from a world-class organization

Qualification

Project ManagementCross-functional ExecutionHigh Ethical StandardsBiotech ExperienceBiotech ConsultingBiotech Investing

Required

You must be enrolled in a distinguished MBA program, anticipating graduating in the Spring/Summer of 2026
You are a self-starter with an entrepreneurial spirit
You are passionate about Regeneron's mission of science to medicine
You can execute in a cross-functional environment
You possess strong project management skills
You have proven leadership skills in previous roles
You have strong problem-solving skills with the ability to think through complex business problems and propose a path toward arriving at a solution
You have integrity and a dedication to high ethical standards

Preferred

Experience in biotech, biotech consulting, or biotech investing

Benefits

Health and wellness programs
Fitness centers
Equity awards
Annual bonuses
Paid time off

Company

Regeneron

company-logo
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.

Funding

Current Stage
Public Company
Total Funding
$15.93M
Key Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M

Leadership Team

leader-logo
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
linkedin
leader-logo
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
linkedin
Company data provided by crunchbase